Stéphanie Braillard

As a member of the Integrated Clinical Development Sciences Department, Stéphanie Braillard is leading the Nonclinical Development of the DNDi portfolio from preclinical nomination and all along the clinical development.

Stéphanie initially joined DNDi in 2011 as a Project Coordinator for Lead Optimisation and Preclinical projects, transitioning to a Senior Manager role in 2017 within the Discovery team. From 2019, she has been a member of the Translation Sciences team where she directed nonclinical activities and led R&D projects.

Prior to joining DNDi, Stéphanie served as Scientist at Athelas SA, a startup company active in the field of anti-bacterial drug discovery, and as Project Manager and Head of Bioanalytics for Med Discovery SA, a biotech company dedicated to the development of treatments for onco-urology.

Stéphanie holds a master’s degree in Molecular and Cellular Biology from the University of Lausanne.